Experience with Hemodialysis Patients in the COVID-19 Pandemic in Sakarya, Turkey
| العنوان: | Experience with Hemodialysis Patients in the COVID-19 Pandemic in Sakarya, Turkey |
|---|---|
| المؤلفون: | Oguz Karabay, Aysel Tocoglu, Savas Sipahi, Hamad Dheir |
| المصدر: | Journal of the College of Physicians and Surgeons Pakistan. 30:138-138 |
| بيانات النشر: | College of Physicians and Surgeons Pakistan, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Nephrology, medicine.medical_specialty, Oseltamivir, Pediatrics, Turkey, medicine.medical_treatment, Pneumonia, Viral, Ambulatory Care Facilities, Antiviral Agents, Betacoronavirus, chemistry.chemical_compound, COVID-19 Testing, Renal Dialysis, Risk Factors, Internal medicine, medicine, Humans, Infectious disease (athletes), Pandemics, Dialysis, Infection Control, Clinical Laboratory Techniques, SARS-CoV-2, business.industry, COVID-19, General Medicine, medicine.disease, Pneumonia, chemistry, Ambulatory, Hemodialysis, Coronavirus Infections, business, Kidney disease |
| الوصف: | The novel coronavirus disease 2019 (COVID-19) is a newly discovered infectious disease. Severe Acute Respiratory Syndrome Infection Coronavirus 2 (SARS-CoV-2) initially manifests as an acute respiratory disease with interstitial and alveolar pneumonia;however, it can affect multiple organs such as kidneys, heart, digestive tract, blood and nervous system.The infection started in Wuhan, Hubei province in China, in December 2019 and has spread rapidly, raising concerns since it became a pandemic global. COVID-19 progresses with increased morbidity and mortality in patients with chronic disease. In addition, this infection deserves special evaluation and a plan of action for dialysis patients, kidney transplant patients, chronic kidney disease patients and other nephrology patients. At public and private dialysis centers in Sakarya province, Turkey, 852 patients have been treated and followed up in chronic hemodialysis programs. Since the epidemic of this disease and the identification of the first case in Sakarya, Turkey, the Department of Nephrology contacted all dialysis centers in province. Since patients are transported collectively with the service system across the province, they provide all drivers with digital thermometers, so they can take each patient's temperature before boarding the bus. Therefore, they sent all their regular dialysis patients to other centers to prevent healthy patients from meeting patients infected with COVID-19. Thus, the pooled all symptomatic patients in one center and protected the other. All dialysis patients diagnosed with COVID-19 were hospitalised. They were treated with oseltamivir, hydroxychloroquine, and azithromycin. In addition, they all have had pulmonary CT scans (low dose). In the clinic, seven patients are still being treated and followed;38 patients have been discharged;however, they are still receiving dialysis treatment in the ambulatory centre. In Sakarya, six dialysis patients died from the COVID-19 infection. Although, they are not sure what the future holds in this long running process, they think that with this strategy, that they planned and executed, they can overcome this process with minimum loss of life. |
| تدمد: | 1681-7168 1022-386X |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::913bfee5ab9c61b405fc9e5c72668074 https://doi.org/10.29271/jcpsp.2020.supp2.138 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....913bfee5ab9c61b405fc9e5c72668074 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 16817168 1022386X |
|---|